Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham G Hartzema

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
American Journal of Obstetrics and Gynecology|October 1, 2016
Comments on prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tractAbraham G Hartzema
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 16, 2004
Intranasal vaccine for prevention of influenza in childrenAbraham G Hartzema
Sleep Medicine|December 28, 2018
Decline in dopamine agonists prescribing and characteristics of drugs prescribed during ambulatory office visits for restless legs syndrome: the National Ambulatory Medical Care Survey 2007-2015Juhyeun Kim, Abraham G Hartzema
Sleep Medicine|March 14, 2018
Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndromeJuhyeun Kim, Abraham G Hartzema
Obesity Research & Clinical Practice|December 30, 2019
Metabolic syndrome and metabolically healthy status in adults with overweight or obesity, expressing no desire to lose weightJuhyeun Kim, Abraham G Hartzema
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2013
Is fidaxomicin worth the cost? The verdict is still out!Abraham G Hartzema, Chao Chen
The Annals of Pharmacotherapy|December 7, 2013
Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic developmentDonna R Rivera, Abraham G Hartzema
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Pharmacy-specific quality indicators for asthma therapyAlmut G Winterstein, Abraham G Hartzema
Journal of Asthma and Allergy|June 13, 2012
Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reportingAyad K Ali, Abraham G Hartzema
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
Cost-utility analysis of rimonabant in the treatment of obesityChristian Hampp, Abraham G Hartzema, Teresa L Kauf
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
American Journal of Obstetrics and Gynecology|October 1, 2016
Comments on prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tractAbraham G Hartzema
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 16, 2004
Intranasal vaccine for prevention of influenza in childrenAbraham G Hartzema
Sleep Medicine|December 28, 2018
Decline in dopamine agonists prescribing and characteristics of drugs prescribed during ambulatory office visits for restless legs syndrome: the National Ambulatory Medical Care Survey 2007-2015Juhyeun Kim, Abraham G Hartzema
Sleep Medicine|March 14, 2018
Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndromeJuhyeun Kim, Abraham G Hartzema
Obesity Research & Clinical Practice|December 30, 2019
Metabolic syndrome and metabolically healthy status in adults with overweight or obesity, expressing no desire to lose weightJuhyeun Kim, Abraham G Hartzema
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2013
Is fidaxomicin worth the cost? The verdict is still out!Abraham G Hartzema, Chao Chen
The Annals of Pharmacotherapy|December 7, 2013
Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic developmentDonna R Rivera, Abraham G Hartzema
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Pharmacy-specific quality indicators for asthma therapyAlmut G Winterstein, Abraham G Hartzema
Journal of Asthma and Allergy|June 13, 2012
Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reportingAyad K Ali, Abraham G Hartzema
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
Cost-utility analysis of rimonabant in the treatment of obesityChristian Hampp, Abraham G Hartzema, Teresa L Kauf
Pageof 6